好了 大家好 All right.大家好。我是《端点新闻》（Endpoints News）的发行人阿萨兰-阿里夫（Arsalan Arif），很高兴担任今天的主持人。今天的网络研讨会由澳大利亚 Agilex Biolabs 公司赞助，我们的主题是 "澳大利亚的优势"--降低早期试验风险。今天和我一起的是 Agilex Biolabs 公司的 Kurt Sales 博士。他有一个大约 20 分钟的演讲，我们将在演讲后进行快速问答。现在有请库尔特-赛尔斯博士。
30
七月
Agilex Biolabs, Australia’s largest specialist bioanalytical laboratory for clinical trials, encouraged biotechs to consider Australia for their clinical trials during a presentation at BIO Digital 2020.
Agilex Biolabs, Australia’s largest specialist bioanalytical laboratory for biotech clinical trials, is presenting the Australian Advantage including the world’s most attractive rebate on clinical trials costs, at BIO Korea 2020.
The reality is, Australia has fantastic key opinion leaders, some great principal investigators that have been running clinical trials for decades. The CROs, RFA with FDA and EMA requirements. And in fact, our whole Australian service provision industry sets itself to that standard because ultimately that is the client base that Australia is servicing. Most CROs in Australia and service providers will be able to talk about situations where their data has been presented to the FDA or EMA with success.
https://youtu.be/WNdPGkdr9FA...
Video https://www.youtube.com/watch?v=sCUT8qtlRX4&feature=youtu.be...
Award-winning Australian bioanalytical laboratory Agilex Biolabs announced today it has appointed US-based Dr Caroline Popper, MBBS, MPH as Board Chair as part of its APAC clinical trials bioanalytics growth plans.
Award-winning Australian bioanalytical laboratory Agilex Biolabs announced today it has appointed PhD and NHMRC Fellow Patrick Hughes as R&D Manager Immunobiology.
Award-winning Agilex Biolabs, the Asia-Pacific region’s leading bioanalytical laboratory based in Australia, announced a raft of new pharmacodynamics services for biotech and pharma clients conducting preclinical and clinical trials in Asia, US, EU and Australia.
Australia-based Agilex Biolabs announced a broad range of new pharmacodynamics services for biopharma clients running preclinical and clinical trials in the U.S., Asia, European Union and Australia.
